Добірка наукової літератури з теми "Bollette"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Bollette".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Bollette"
van Drumpt, Majorie, Marlous Huijzer, Bob Bloemendaal, and Jolien van de Pol. "Een buik vol bolletjes." Critical Care 11, no. 1 (February 2014): 6–10. http://dx.doi.org/10.1007/s12426-014-0011-0.
Повний текст джерелаColetti, Vittorio. "Il prezzo può essere ivato." XII, 2020/1 (gennaio-marzo) 12, no. 1 (March 24, 2020): 68–69. http://dx.doi.org/10.35948/2532-9006/2020.3274.
Повний текст джерелаRyskova, Lenka, Radka Bolehovska, Rudolf Kukla, Michal Svarc, Alzbeta Zavrelova, Hubert Vanicek, Ivo Pavlik, and Pavel Bostik. "Mycobacterioses Induced by Mycobacterium abscessus: Case Studies Indicating the Importance of Molecular Analysis for the Identification of Antibiotic Resistance." Antibiotics 11, no. 7 (June 28, 2022): 873. http://dx.doi.org/10.3390/antibiotics11070873.
Повний текст джерелаFleischer, Soraya, Raquel Lustosa da Costa Alves, Rosamaria Giatti Carneiro, Camila Vaz Neto Ferreira Correia, and Júlia Vilela Garcia. "COMO FAZER PESQUISA ANTROPÓLOGICA DURANTE A PANDEMIA DO COVID-19?" Revista Pós Ciências Sociais 19, no. 2 (June 30, 2022): 247–434. http://dx.doi.org/10.18764/2236-9473v19n2.2022.20.
Повний текст джерелаRollet-Cohen, Virginie, Anne-Laure Roux, Muriel Le Bourgeois, Guillaume Sapriel, Manele El Bahri, Jean-Philippe Jais, Beate Heym, et al. "Mycobacterium bolletii Lung Disease in Cystic Fibrosis." Chest 156, no. 2 (August 2019): 247–54. http://dx.doi.org/10.1016/j.chest.2019.03.019.
Повний текст джерелаHenao-Martínez, Andrés F., Nancy Olague, and Carlos Franco-Paredes. "Spontaneous Mycobacterium bolletti skin abscesses — An underrecognized zoonosis from raw bovine milk." Travel Medicine and Infectious Disease 22 (March 2018): 77–78. http://dx.doi.org/10.1016/j.tmaid.2018.01.003.
Повний текст джерелаJoseph, C., C. Petit, J. L. Schmit, M. Drancourt, E. Pluquet, and J. P. Lanoix. "Community-acquired granulomatous mastitis superinfected with Mycobacterium bolletii." Médecine et Maladies Infectieuses 50, no. 3 (May 2020): 291–92. http://dx.doi.org/10.1016/j.medmal.2019.11.002.
Повний текст джерелаChoi, G. E., Y. J. Cho, W. J. Koh, J. Chun, S. N. Cho, and S. J. Shin. "Draft Genome Sequence of Mycobacterium abscessus subsp. bolletii BDT." Journal of Bacteriology 194, no. 10 (April 24, 2012): 2756–57. http://dx.doi.org/10.1128/jb.00354-12.
Повний текст джерелаWertman, Rebecca, Melissa Miller, Pamela Groben, Dean S. Morrell, and Donna A. Culton. "Mycobacterium bolletii/Mycobacterium massiliense Furunculosis Associated With Pedicure Footbaths." Archives of Dermatology 147, no. 4 (April 11, 2011): 454. http://dx.doi.org/10.1001/archdermatol.2011.58.
Повний текст джерелаvan Dijk, Theon. "Het CBb komt er uit voor Bolletje-beschuit: ACM bakt het al te bruin." Markt en Mededinging 19, no. 5 (November 2016): 209–15. http://dx.doi.org/10.5553/menm/138762362016019005007.
Повний текст джерелаДисертації з теми "Bollette"
Koopmans, Marion P. G. "Bolletjes slikken." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10423.
Повний текст джерелаMüller-Kelwing, Karin. "Martin Bollert." Böhlau Verlag, 2020. https://slub.qucosa.de/id/qucosa%3A75034.
Повний текст джерелаNeves, Rogério Coutinho das. "Prospecção de peptídeos derivados das peçonhas de animais da Região Centro Oeste com atividade antimicobacteriana." Universidade Federal de Goiás, 2015. http://repositorio.bc.ufg.br/tede/handle/tede/5584.
Повний текст джерелаApproved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-05-20T11:12:51Z (GMT) No. of bitstreams: 2 Dissertação - Rogerio Coutinho das Neves - 2015.pdf: 6048850 bytes, checksum: 1bac6d1d4aa28a3cf0ebbb228b593986 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Made available in DSpace on 2016-05-20T11:12:51Z (GMT). No. of bitstreams: 2 Dissertação - Rogerio Coutinho das Neves - 2015.pdf: 6048850 bytes, checksum: 1bac6d1d4aa28a3cf0ebbb228b593986 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-02-27
Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq
Outbreaks caused by atypical mycobacteria are considered as an emerging problem in Brazil and Goias, being frequently associated with invasive procedures, such as laparoscopy, arthroscopy, and aesthetic surgeries among others. Treatment of mycobacteriosis requires highly toxic drugs with doubtful sterilizing effects. Consequently, several studies aim to search for new drugs or molecules with anti-mycobacterial biological activities. The objective of this study was to prospect biomolecules from the venom of the social wasp Polybia paulista (Vespoidea, Vespidae, Polistinae) and from the Tityus sp scorpion with antimycobacteria activity against Mycobacterium abscessus subsp. bolletii (GO06). Peptides from the wasp and scorpion venoms were evaluated in broth microdilution assay and in macrophage infected cultures to determine minimum inhibitory concentration. Peptides with antimycobacterial activity were further evaluated by scanning electron microscopy of M. abscessus subsp. bolletii treated cultures. The peptide toxicities were evaluated on macrophage cultures. Peptides Agelaia-MP, Polybia-MPII, and AVA, derived from wasp and peptides AMP 1, 2, 4, 6, and 8 derived from scorpion presented antimycobacterial activities. AVA and AMP 4 peptides were not toxic for macrophages. In this work three peptides derived from the wasp venom and five peptides derived from the scorpion venom were identified as having antimycobacterial activity.
Surtos causados por micobactérias atípicas são considerados emergentes no Brasil e em Goiás e têm tem sido associados a procedimentos invasivos, como a laparoscopia, artroscopia e cirurgia estética dentre outros. O tratamento de micobacterioses envolve drogas altamente tóxicas que apresentam efeito esterilizante relativo. Portanto, vários estudos têm como alvo a busca de novas drogas ou moléculas biológicas com atividade micobactericida. O objetivo deste estudo foi prospectar biomoléculas do veneno de vespa social Polybia paulista (Vespoidea, Vespidae, Polistinae) e de escorpiões do gênero Tityus com atividade micobactericida in vitro contra Mycobacterium abscessus subsp. bolletii (GO06). Peptídeos derivados do veneno da vespa e do escorpião foram avaliados por microdiluição em caldo, e em culturas de macrófagos infectados determinando a concentração inibitória mínima. Para os peptídeos com atividade micobactericida, o potencial dano causado à parede celular da micobactéria foi analisado por microscopia eletrônica de varredura. A toxicidade de dois peptídeos com potencial uso farmacológico foram avaliados em culturas de macrófagos peritoneais de camundongos BALB/c. Os peptídeos Agelaia-MP, Polybia-MPII e AVA derivados do veneno da vespa e os peptídeos AMP 1, 2, 4, 6 e 8 derivados do veneno de escorpião apresentaram atividade micobactericida. Os peptídeos micobactericidas agem desestruturando os envoltório das bacilos de M. abscessos subsp. bolletti. Os peptídeos AVA e o AMP 4 não apresentaram toxicidade para culturas de macrófagos, e reduziram a carga bacilar de culturas de macrófagos infectadas com M. abscessus subsp. bolletii. Neste trabalho identificou-se três peptídeos derivados da peçonha de vespa e cinco peptídeos derivados de veneno de escorpião com atividade micobactericida.
Moura, Vinicius Calado Nogueira de. "Caracterização da resistência a quinolonas em Mycobacterium abscessus subsp. bolletii e outras micobactérias de crescimento rápido relacionadas." Universidade do Estado do Rio de Janeiro, 2011. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=6113.
Повний текст джерелаEm diversos estados do Brasil, foram relatadas epidemias de infecções causadas por micobactérias de crescimento rápido (MCR) desde o ano 2000. A maioria dos casos foi principalmente associada ao clone BRA100 de Mycobacterium massiliense, recentemente renomeada para Mycobacterium abscessus subsp. bolletii, isolado de pacientes submetidos a procedimentos invasivos nos quais os instrumentos médicos não foram adequadamente esterilizados e/ou desinfetados. Sendo as quinolonas uma opção no tratamento de infecções por MCR e sugerida para esquemas terapêuticos para esses surtos, foram avaliadas nesse trabalho as atividades in vitro de quatro gerações de quinolonas para cepas clinicas e de referência de MCR através da microdiluição em caldo. Também foram analisadas as sequências peptídicas das regiões determinantes da resistência a quinolonas (RDRQ) das subunidades A e B da DNA gyrase (GyrA e GyrB) após o seqüenciamento de DNA seguido pela tradução da sequência de aminoácidos. Cinquenta e quatro cepas de M. abscessus subsp bolletii, incluindo o clone BRA100, isoladas em diferentes estados do Brasil, e 19 cepas de referência de MCR foram caracterizadas. Todas as 54 cepas clínicas de M. abscessus subsp. bolletii foram resistentes a todas as gerações de quinolonas e mostraram o mesmo resíduo nas RDRQ, incluindo Ala-83 em GyrA, Arg-447 e Asp-464 em GyrB, descritos como sendo responsáveis por gerar um baixo nível de resistência a quinolonas em micobactérias. Porém, outras espécies de MCR apresentaram diferentes susceptibilidade e padrões de mutações contrários aos classicamente já definidos, sugerindo que outros mecanismos de resistência, diferentes de mutações em gyrA e gyrB também possam estar envolvidos na alta resistência a quinolonas.
Several outbreaks of infections caused by rapidly growing mycobacteria (RGM) have been reported in many Brazilian states since 2000. Most of the cases were mainly associated to Mycobacterium massiliense, recently renamed as Mycobacterium abscessus subsp. bolletii, BRA100 clone recovered from patients who had undergone invasive procedures, in which medical instruments have not been properly sterilized and / or disinfected. Since quinolones have represented an option for the treatment of general RGM infections and suggested for therapeutic schemes for these outbreaks, we evaluated the in vitro activities of four generations of quinolones for clinical and reference RGM by broth microdilution, and analysis of peptide sequences of the quinolone resistance determining regions (QRDR) of GyrA and GyrB after DNA sequencing followed by amino acid translation. Fifty four isolates of M. abscessus subsp bolletii, including clone BRA100, recovered in different states of Brazil, and 19 reference strains of RGM species were characterized. All 54 M. abscessus subsp. bolletii isolates were resistant to all generations of quinolones and showed the same amino acids in the QRDR including the Ala-83 in GyrA, Arg-447 and Asp-464 in GyrB, described as responsible for an intrinsic low level of resistance to quinolones in mycobacteria. But other RGM species presented distinct susceptibilities to this class of antimicrobials and patterns of mutations contrary to what has been traditionally defined, suggesting that other mechanisms of resistance, different from gyrA or gyrB mutations, may also be involved in resistance to high levels of quinolones.
Silva, Juliano de Morais Ferreira. "Micobactérias de crescimento rápido de importância médica no Brasil: eficácia antimicrobiana de desinfetantes e sistema de esterilização por plasma." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/9/9139/tde-30092011-153348/.
Повний текст джерелаNumerous outbreaks of Rapid Growth of Mycobacteria (RGM) have been associated with decontamination, disinfection and sterilization malpractices, in Brazil. Between 2000-2008 were reported more than 2,000 confirmed cases due to RGM infections, and the video procedures were considered to carry these microorganisms. The increased use of medical devices in surgical procedures may be involved in the RGM spreading by its ability to grow and survive in biofilm systems. The aim of this study was evaluate the susceptibility of Mycobacterium abscessus subsp. bolletii (outbreak and nonoutbreak strains) to chemical disinfectants: Glutaraldehyde 2%, Peracetic Acid 0.2%, Hydrogen Peroxide 35%, Chlorhexidine Digluconate 0.5%, Chlorhexidine 0.2%, Iodine 1%, Quaternary Ammonium Compounds 1.2%, and Phenol 5%. Plasma Sterilization Technologies (Reactive Ion Etching and Inductively Coupled Plasma) were also evaluated. Polymers employed in medical devices (Polyvinyl chloride, High-Density Polyethylene, Polycarbonate, Polypropylene, and Polyurethane) were analyzed by Photoacoustic Infrared Spectroscopy (PAS-FTIR), Scanning Electron Microscopy (SEM), System Energy Dispersive Spectroscopy (EDS) and Profilometry. The results have demonstrated the resistance of Mycobacterium abscessus subsp. bolletii isolated from the Belém (PA) outbreak considering chemical exposition to Glutaraldehyde 2%, Chlorhexidine Digluconate 0.5%, Chlorhexidine 0.2%, Quaternary Ammonium Compounds 1.2%, and Iodine 2%. However, these strains were highly sensitive to Peracetic Acid 0.2%, Hydrogen Peroxide 35%, and Phenol 5%. The M. abscessus subsp. bolletii strains have been presented resistant to all disinfectants studied, in biofilm systems. Studies involving polymer integrity demonstrated changes in surface (oxidation and roughness) on all processed materials, and the ICP system was more aggressive in contrast to Reactive Ion Etching.
D'Ostilio, Debora. "Sviluppo di un programma per il calcolo del termine sorgente ai fini della valutazione del rischio." Master's thesis, Alma Mater Studiorum - Università di Bologna, 2019.
Знайти повний текст джерелаNogueira, João Sobrinho Simões Aguiar. "Recozimento de homogeneização da liga 6063 na empresa SAPA II Perfis." Master's thesis, 2012. http://hdl.handle.net/10216/72644.
Повний текст джерелаNogueira, João Sobrinho Simões Aguiar. "Recozimento de homogeneização da liga 6063 na empresa SAPA II Perfis." Master's thesis, 2012. https://repositorio-aberto.up.pt/handle/10216/65031.
Повний текст джерелаNogueira, João Sobrinho Simões Aguiar. "Recozimento de homogeneização da liga 6063 na empresa SAPA II Perfis." Dissertação, 2012. http://hdl.handle.net/10216/72644.
Повний текст джерелаКниги з теми "Bollette"
Brands, G. Bolletje. Amsterdam: Querido, 1988.
Знайти повний текст джерелаTullio, De Mauro, and Vedovelli Massimo, eds. Dante, il gendarme e la bolletta: La comunicazione pubblica in Italia e la nuova bolletta Enel. [Rome]: Laterza, 1999.
Знайти повний текст джерелаAnjo, Kan, ed. Bolletje Aarde en haar zee: Kijk, dicht, doe mee. [Wijdewormer]: www.bolletjeaarde.nl, 2013.
Знайти повний текст джерелаBignan, Marianne. Bollène: Des origines au XIXe siècle. Paris: Office d'édition du livre d'histoire, 1998.
Знайти повний текст джерелаFoddis, Guido. Il giro a sbafo: L'incredibile scommessa della maglia rosa in bolletta. Portogruaro (Ve) [i.e. Venice, Italy]: Ediciclo, 2011.
Знайти повний текст джерелаL'Italia in bolletta: Risparmi in fumo, debiti alle stelle : come si estingue il ceto medio. Milano: Garzanti, 2009.
Знайти повний текст джерелаDelaperrelle, Jean-Pierre. L' invention de l'automobile: Bollée : de la vapeur au turbo. [Le Mans]: Editions Cénomane, 1986.
Знайти повний текст джерелаRenate, Eikelmann, Weniger Matthias, Burk Jens Ludwig, and Bayerisches Nationalmuseum, eds. Die Sammlung Bollert: Bildwerke aus Gotik und Renaissance, Bayerisches Nationalmuseum. München: Hirmer Verlag, 2005.
Знайти повний текст джерелаOpera, Andrea. Risparmia Sulle Tue Bollette Luce e Gas: Confessioni Di un Operatore Call Center. Independently Published, 2022.
Знайти повний текст джерелаSanders, Jill. Un bollente Natale. Independently published, 2018.
Знайти повний текст джерелаЧастини книг з теми "Bollette"
Delaere, P. "Een ‘bolletje’ laag in de hals." In Keel-neus-oorheelkunde en hoofd-halschirurgie, 165–69. Houten: Bohn Stafleu van Loghum, 2008. http://dx.doi.org/10.1007/978-90-313-6539-5_38.
Повний текст джерела